Birgitte Offersen showing the results of Skagen1 trial - hypofx vs conventional RT in high risk breast cancer patients with indication for lymphnode irradiation. Same side effects, same local control but worse survival. Due to lower RT dose? #ESTRO25 #RadOnk
1
1
0
0